Pharmaceutical

Difficult biotech investment ecosystem forces focus on value

In 2023, investors pursued pharmaceutical assets with value amidst an unstable economic environment.

Dec 28, 2023 - 18:00
Difficult biotech investment ecosystem forces focus on value
In 2023, investors pursued pharmaceutical assets with value amidst an unstable economic environment.
Read the original article

Tags:

Previous Article

Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn

Next Article

Molecules exhibit non-reciprocal interactions without external forces, new study...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Shionogi secures licence for Maze’s Pompe disease treatment

Shionogi secures licence for Maze’s Pompe disease treat...

May 11, 2024

His book on the opioid crisis flopped in 2003. It now has a new life on Netflix

His book on the opioid crisis flopped in 2003. It now h...

Jul 28, 2023

New England Journal of Medicine reckons with its racist past and complicity in slavery

New England Journal of Medicine reckons with its racist...

Dec 7, 2023